Talecris Raises $950 Million in I.P.O.

Talecris Biotherapeutics Holdings raised $950 million in the second-largest initial public offering in the U.S. this year.

whole article   nytimes.com,     opinion
  01.10.2009. 13:00h

Keywords:

Related articles:

  • There are no related articles